LONDON, Sept. 14, 2017 /PRNewswire/ -- The global fluoroscopy equipment market is projected to reach USD 2.79 billion by 2022 from USD 2.21 billion in 2017, at a CAGR of 4.8% during the forecast period. The key factors driving the growth of this market include the use of modern flat panel detectors instead of the traditional image intensifiers, rising prevalence of cardiovascular diseases (CVDs) globally, and growing popularity of multipurpose imaging systems. However, the risk of radiation associated with the exposure to radiographic imaging may hinder the growth of this market to a certain extent during the forecast period.
Download the full report: https://www.reportbuyer.com/product/5100648
"By application, the surgical application segment to witness the highest growth during the forecast period (2017-2022)"
Ad Statistics
Times Displayed: 112999
Times Visited: 6736 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
Based on application, the market is segmented into diagnostic applications and surgical applications. The diagnostic application segment is expected to account for the largest share of the market. However, the surgical application is expected to grow at a Higher CAGR during the forecast period. The segment is further segmented into orthopedic and trauma surgeries, neurosurgeries, cardiovascular surgeries, gastrointestinal surgeries, and other surgical applications (urologic surgeries, endobronchial and thoracic surgeries, and maxillofacial surgeries). The orthopedic and trauma surgeries segment is expected to dominate the fluoroscopy equipment market for surgical applications.
"Asia Pacific (APAC) to witness the highest growth during the forecast period"
APAC is expected to witness the highest growth during the forecast period. Growing healthcare expenditure, rising geriatric population, and the increasing number of surgical procedures associated with growing prevalence of chronic diseases are the key factors responsible for the growth of this market in the APAC region.
Break of primary participants was as mentioned below:
• By Company Type – Tier 1–55%, Tier 2–25% and Tier 3–20%
• By Designation – C-level–43%, Director Level–32%, Others–25%
• By Region – North America–38%, Europe–23%, Asia-Pacific–29%, RoW–10%
The key players in the global fluoroscopy equipment market are Siemens AG(Germany), GE Healthcare(US), Koninklijke Philips N.V. (Netherlands), Shimadzu Corporation (Japan), Ziehm Imaging GmbH (Germany), Toshiba Medical Systems Corporation (Japan), Hitachi Ltd. (Japan), Carestream Health, Inc. (US), Hologic, Inc. (US), Lepu Medical Technology Co., Ltd. (China), Agfa-Gevaert Group (Belgium), and Adani Systems Inc. (Belarus).
